Patent · US Active

Therapy for hyperexcitability disorders

US9308183B2 · kind B2 · utility

0Cited by

9References

20Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Cara Heers · Monheim, DE
Thomas Stoehr · Witten, DE
Bettina Beyreuther · Mülheim an der Ruhr, DE

Key dates

Filing date	Jun 29, 2007
Grant date	Apr 12, 2016
Priority date	—
Expiry date	Jun 10, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to the use of a class of peptide compounds for treating diseases associated with hyperexcitability. The present invention is also directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.